abstract |
1-α-Fluoro-25-hydroxy-16,23E-diene-26,27-bishomo-20- for the manufacture of a medicament for the prevention and / or treatment of benign prostatic hyperplasia (BPH) and associated symptoms Use of epi-cholecalciferol, or a pharmaceutically acceptable salt or ester thereof. |